Analyzing Mitotic Chromosome Structural Defects After Topoisomerase II Inhibition or Mutation.
- Citation data:
Methods in molecular biology (Clifton, N.J.), ISSN: 1940-6029, Vol: 1703, Page: 191-215
- Publication Year:
- Captures 2
- Readers 2
- Mendeley 2
- Biochemistry, Genetics and Molecular Biology
book chapter description
For analyzing chromosome structural defects that result from topoisomerase II (topo II) dysfunction we have adapted classical cell cycle experiments, classical cytological techniques and the use of a potent topo II inhibitor (ICRF-193). In this chapter, we describe in detail the protocols used and we discuss the rational for our choice and for the adaptations applied. We clarify in which cell cycle stages each of the different chromosomal aberrations induced by inhibiting topo II takes place: lack of chromosome segregation, undercondensation, lack of sister chromatid resolution, and lack of chromosome individualization. We also put these observations into the context of the two topo II-dependent cell cycle checkpoints. In addition, we have devised a system to analyze phenotypes that result when topo II is mutated in human cells. This serves as an alternative strategy to the use of topo II inhibitors to perturb topo II function.